Gleiss Lutz offers longstanding expertise in statutory health insurance issues and advises on pharmaceutical pricing law matters as well as contractual and data protection issues. The team also regularly leads in court, arbitration and administrative proceedings, most recently in connection with care management, fee regulations and recourse claims by Covid-19 vaccine manufacturers pertaining to exemption agreements. The team is led by Martin Viciano Gofferje, who focuses on transactions and joint ventures, and Reimar Buchner (administrative and medical law). Christine Mattes cover matters at the interface between health and procurement law, where she regularly advises both clients and buyers. Enno Burk was appointed to partner in January 2024 and handles pharmaceutical and medical device law matters with a particular focus on digitisation.
Testimonials
Collated independently by Legal 500 research team.
'We have always received competent support in a timely manner in critical situations. Even when our main contact person was absent, this was ensured by a substitute. All appointments are kept to the utmost precision.'
'Marco König has given us optimal support at all times.'
'The law firm has an exceptionally high level of professionalism, a very high level of expertise and the highest level of service. It stands out due to its very fast response times and exceptionally high quality. The collaboration is friendly, fair and uncomplicated.'
'Marco König and Reimar Buchner have outstanding technical expertise and a great deal of experience in the healthcare market. The level of advice, the good cooperation and the quick comprehension characterize the two lawyers and their teams.'
'Gleiss Lutz offers full service in healthcare law. The healthcare team in Stuttgart seamlessly incorporates all interfaces and all necessary legal areas into the consultation, so that the client always experiences advice from a single source. The experience and competence in healthcare law as a consultant on behalf of statutory health insurance companies is unparalleled in the market.'
'Consistently excellent communication and strategic advice. Extremely client-focused and goal-oriented approach with a clear eye for what is essential.'
'Extremely harmonious and excellent team, incredible experience and expertise, always available, always to the point. Excellent collaboration that is really fun. Above all, everyone thinks for themselves and has the bigger picture in mind.'
Key clients
- AOK-Bundesverband
- kubus IT GbR
- Landkreis Calw
- mhplus BKK
- Bioscientia Healthcare GmbH
- Bundesgesundheitsministerium
- Paul Ehrlich-Institut
- Bundesinstitut für Arzneimittel und Medizinprodukte
- Fraunhofer Gesellschaft
- Trinity Biotech plc
- Pitango International
- Carl Zeiss Meditec AG
- MAYD Group GmbH
- Roche
- Karl Storz SE & Co. KG
- Paracelsus-Kliniken / Porterhouse
- Verband der Ersatzkassen e.V.
- Kassenärztliche Bundesvereinigung
Work highlights
- Advising and representing the Federal Republic of Germany (Federal Ministry of Health/Paul Ehrlich Institute/Federal Institute for Drugs and Medical Devices) in the defense against recourse claims by COVID-19 vaccine manufacturers due to exemption agreements under EU treaties.
- Comprehensive advice to start-up MAYD (Medicines at your doorstep), which offers delivery of pharmaceuticals to the respective address of the purchaser within 30 minutes in metropolitan areas via an app with cooperating pharmacies.
- Comprehensive advice and support to all AOKs under the leadership of AOK Baden-Württemberg in Europe-wide tenders by AOKs for pharmaceutical discount agreements in the generics sector.